Trials / Unknown
UnknownNCT02916277
Endocan in Ventilator-associated Pneumonia
Endocan; Can be a New Biomarker in Ventilator-associated Pneumonia?
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Erzincan University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study; in patients undergoing mechanical ventilation, making the day series Endocan measurements during the first 5 day to look at whether there is a relationship between the levels of VAP with Endocan. This relationship, if any, aimed to investigate whether correlated with clinical and laboratory findings \[presence of fever, pathological lung X-ray, the number of white blood cells (WBC), procalcitonin (PCT), C-reactive protein (CRP)\] .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | endocan | to look series Endocan level for 5 days in intubated patients |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-02-01
- Completion
- 2017-03-01
- First posted
- 2016-09-27
- Last updated
- 2016-09-27
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02916277. Inclusion in this directory is not an endorsement.